This Persistence Market Research (PMR) report examines the ‘Global Postoperative Pain Management Market’ for the period 2018–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global Postoperative Pain Management Market.
The Postoperative Pain Management Market is segmented as Follows:
This report covers the global Postoperative Pain Management Market performance in terms of revenue contribution from various segments. The report begins with an overview of the postoperative pain management and its definitions. The market viewpoints section underlines macro-economic factors influencing the growth of the postoperative pain management market along with detailing its opportunity analysis.
The global Postoperative Pain Management Market is segmented based on drug class, route of administration, distribution channel and region. On the basis of drug class, the market has been segmented as opioids, NSAIDS, local anaesthetics, and acetaminophen.
On the basis of route of administration, the market has been segmented as Injectable, Oral, Topical, Transdermal, Others.
On the basis of distribution channel, the market is segmented as hospital pharmacies, retail pharmacies, drug store, clinics, others.
A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. The regional market dynamics provide the key growth driver, restraints, and trends pertaining to each region. The forecast of the Postoperative Pain Management Market by country, drug class, route of administration, distribution channel are represented in the tabular form for each region. This section also helps to understand the opportunity of the postoperative pain management market in major countries by each segment. The volume analysis of postoperative pain management is also provided by region. The volume of postoperative pain management is triangulated with the average selling price.
In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. This section also provide wise structure analysis to understand the tier structure of postoperative pain management market. Along with tier structure this section is also assessed market share analysis for top companies to cross validated the postoperative pain management market value. This analysis is done on granular level by analysing the revenue generated by each of the manufacturer from postoperative pain management. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players in the postoperative pain management market are also provided in the report, which highlights company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.
The next section of the report highlights the postoperative pain management market outlook for 2018–2026 and sets the forecast within the context of the postoperative pain management market by region. The key regions assessed in this postoperative pain management market report include North America, Latin America, Europe, Asia Pacific excluding China, China and Middle East and Africa. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. This section helps to analyses the maturity level of all the region in global postoperative pain management market.
The above sections – by drug class, route of administration and distribution channel; evaluate the historic market analysis for the period of 2013–2017 and growth prospects of the postoperative pain management market for the period 2018–2026. Along with historic analysis, market value forecast and Y-o-Y analysis by drug class, route of administration and distribution channel for postoperative pain management market is also provided in this section. We have considered 2017 as the base year and provided data for the forecast period.
The final section of report represents the global scenario for the postoperative pain management market along with Y-o-Y growth and market forecast till 2026. This section also evaluates the global market opportunity over the forecast period and also the absolute dollar opportunity for each year. This section will help to understand the overall market growth of the postoperative pain management market and the opportunity analysis for each year over the forecast period. This section also provide with the volume analysis for global postoperative pain management market to analyse the global sale of postoperative pain management drugs.
Initially top down analysis is used to calculate the market size of global postoperative pain management market. Firstly total number of surgical procedure performed annually in top 20 countries is analysed by secondary research.
The number of surgery performed and treated for postoperative pain management is also differentiated for top 20 countries.
The Number of procedure perform by surgeon and number of postoperative pain management prescriptions is confirmed by primary interviews with surgeon and nurses to analyse the volume of postoperative pain management drugs. Prices of various carpal tunnel release systems available in the market are analysed to calculate the average selling price of postoperative pain management drugs by weighted average methodology. The volume of postoperative pain management drugs is them multiplied with average selling price to obtain the market value of postoperative pain management in 2017 for top countries.
Bottom-up approach is used to validate the total market size obtained. The forecast presented in the report provides total revenue of the postoperative pain management market over 2018–2026. While forecasting the market size, we have considered the impact of several factors such product approvals for postoperative pain management drugs, R&D investment by major players, pipeline analysis, penetration of products in all Distribution channel, generic penetration across all regions, etc. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.
Market Value and Forecast
The global postoperative pain management market is expected to be worth US$ 45,861.8 Mn in 2026, it is projected to increase at a CAGR of 5.1% through 2026. North America was the dominant regional market for postoperative pain management, accounting for US$ 12458.3 Mn in 2017, and is expected to grow at a CAGR of 4.4% over the forecast period (2018–2026).
Factors and Trends Impacting the Growth of the Market
The continuously growing population and increasing awareness about the surgical treatments in cancer and other chronic diseases such as chronic obstructive pulmonary disorder (COPD) is expected to impel the demand for postoperative pain management market.
Thus, changing healthcare scenario and growing awareness about the postsurgical pain and trauma is expected to increase the awareness about postoperative pain management, and consequently propel the demand for postoperative pain management globally.
As per the American Cancer Society, the global incidence of cancer was 14.09 Mn in 2012, where approximately 20–30% out of total cancer patients required to undergo surgery and required postoperative pain management drugs to overcome the pain. By 2030, the global burden of cancer is expected to grow to 21.70 Mn new cancer cases majorly due to growing ageing population. Cancer removal procedures involving mastectomy or lumpectomy require high dosage of postoperative pain management drugs. The growing prevalence of cancer is another factor expected to impel the growth of the postoperative pain management market.
As per the International Association for the Study of Pain, the prevalence of postoperative pain in general population is 3–4%. The increasing number of surgical procedures and surgical interventions in various disease conditions is expected to create immense growth opportunities for the postoperative pain management market.
According to the WHO modeling of data from member nations, it is estimated that nearly 234.2 million surgical procedures were performed in 2004. Approximately around 60-70% patient experience moderate to severe pain just after 24 hours of surgery. All the patient undergone surgery required to be treated postoperative pain management drugs.
The persistently changing lifestyle preferences and choices such as cosmetic reconstruction and plastic surgery is impacting the growth of the postoperative pain management market. Continuous efforts by the manufacturers to develop new non-opioid drugs for global postoperative pain management market is anticipated to fuel competition in the manufactures of postoperative pain management drugs.
Geographically, the global postoperative pain management market has been segmented into North America, Latin America, Europe, Europe, Asia-Pacific excluding China, China and Middle East & Africa. North America is assessed to dominate the global postoperative pain management market over the forecast period. The North America postoperative pain management market is projected to grow at a CAGR of 4.4% over the forecast period to reach a value of US$ 20,580.5 Mn. Well-developed healthcare infrastructure and higher healthcare spending coupled with rising prevalence of cancer and chronic diseases are some of the primary factors expected to drive the growth of the postoperative pain management market in North America.
Examples of some of the key players operating in the global postoperative pain management market are Teva Pharmaceutical Industries Ltd., Novartis AG, Allergan plc., Mylan N.V., Pfizer Inc., Purdue Pharma L.P, Janssen Pharmaceuticals, Inc., Endo International plc., Pacira Pharmaceuticals Inc., Egalet Corporation., and GlaxoSmithKline Plc. Key market player such as Purdue is continuously developing abuse deterrent formulation, which offers the manufacturer an edge in postoperative pain management market. The leading players are focusing on development of novel drug delivery system for opioids postoperative pain management drugs and promoting the use of NSAIDs for the treatment of postoperative pain. Some of the companies are focusing on developing abuse deterrent drugs for postoperative pain management. Consequently, extensive efforts by the manufacturers are expected to fuel the competition in the global postoperative pain management market.